A016

Whan In Pharm Co.,Ltd. Stock Price

KOSE:A016580 Community·₩165.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A016580 Share Price Performance

₩10,820.00
-2450.00 (-18.46%)
₩10,820.00
-2450.00 (-18.46%)
Price ₩10,820.00

A016580 Community Narratives

There are no narratives available yet.

Recent A016580 News & Updates

Whan In Pharm Co.,Ltd. Key Details

₩258.7b

Revenue

₩173.1b

Cost of Revenue

₩85.6b

Gross Profit

₩69.2b

Other Expenses

₩16.4b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
1.07k
Gross Margin
33.09%
Net Profit Margin
6.34%
Debt/Equity Ratio
0%

Whan In Pharm Co.,Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and fair value.

2 Risks
3 Rewards

About A016580

Founded
1978
Employees
605
CEO
Kwang-Sik Lee
WebsiteView website
www.whanin.com

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

South Korean Market Performance

  • 7 Days: 3.3%
  • 3 Months: 13.3%
  • 1 Year: 32.8%
  • Year to Date: 44.6%
The market is up 3.3% over the last week, with the Information Technology sector leading the way, up 7.1%. As for the past 12 months, the market is up 33%. Looking forward, earnings are forecast to grow by 24% annually. Market details ›